Abstract. The aim of the present study was to elucidate the characteristics and outcomes of abdominal esophageal cancer patients who were treated with esophagectomy. The records of 210 esophagectomy patients were retrospectively reviewed and the differences in postoperative outcomes and disease-specific survival between squamous cell carcinoma and adenocarcinoma were evaluated. Of the 20 abdominal esophageal cancer patients, 11 had squamous cell carcinoma, 8 had adenocarcinoma and 1 had adenosquamous cell carcinoma. The body mass index and serum albumin levels were significantly lower in the squamous cell carcinoma patients compared with those in the adenocarcinoma patients, and abdominal lymph node metastasis was significantly more frequent in the adenocarcinoma patients. Early recurrence occurred in 5 patients who had postoperative surgical site infection, microscopic residual cancer, and mediastinal lymph node metastasis. A Kaplan-Meier curve indicated a significantly shorter survival time in patients who underwent surgery with a thoraco-abdominal approach, who had postoperative complications, and who had microscopic residual cancer. This study demonstrated the significance of R0 resection and prevention of postoperative complications in improving the prognosis of patients with abdominal esophageal cancer.
Introduction
Esophageal squamous cell carcinoma (SCC) of the thoracic esophagus is common in Asia (1) . In Japan, >85% of esophageal carcinoma cases are located in the thoracic part of the esophagus (2), and preoperative chemotherapy followed by radical esophagectomy with three-field lymphadenectomy is considered to be the standard treatment (3) . In Western countries, adenocarcinoma (adenoCa) of the esophago-gastric junction (EGJ) is common (4) , and is mainly treated by preoperative chemoradiotherapy followed by surgery (5,6).
Siewert et al classified EGJ carcinoma into three types (7), namely type I (abdominal esophageal carcinoma), type II (true carcinoma of the cardia), and type III (gastric cancer). A Japanese randomized controlled study recommended an abdominal approach rather than a left thoraco-abdominal approach (TAA) for patients with type II and III EGJ adenoCa (8) . However, there have been few reports regarding the optimal treatment method for patients with abdominal esophageal cancer (AEC), including SCC (Siewert type I cancer).
The aim of the present study was to elucidate the characteristics and outcomes of AEC patients who were treated with esophagectomy.
Patients and methods

Patients.
A total of 210 patients who had undergone esophagectomy between June 1999 and March 2017 were retrospectively reviewed. AEC was defined as cancer located in the abdominal esophagus (from the hiatus to the EGJ), >2 cm above the EGJ. Among all patients, 20 (9.5%) were diagnosed with AEC. All the patients underwent preoperative endoscopy, computed tomography and esophagography to confirm the clinical diagnosis and determine the surgical approach. The right TAA was adopted for patients with cancer tissue extending >3 cm above the EGJ, or with lymph node metastases (LNM) in the neck or the mediastinum.
The clinicopathological characteristics of the patients, including age, sex, histological type, TNM stage, nutritional status, use of neoadjuvant chemotherapy (NAC), surgical approach (right thoraco-abdominal or abdominal), postoperative complications, pathological findings, use of adjuvant chemotherapy and postoperative overall survival, were evaluated. The nutritional status included body mass index (BMI) and serum albumin levels. Postoperative complications included pneumonia, anastomotic leakage and surgical site infection (SSI) grade >II according to the Clavien-Dindo classification (9) . The pathological findings included microscopic residual disease (R1), number of LNM and location of the LNM.
Three analyses were then performed. First, the differences in these findings were compared between SCC and adenoCa. The differences between the SCC and the adenoCa groups are summarized in Table II . Patients in the SCC group were older compared with those in the adenoCa group, although age was not significantly associated with poor disease-specific survival. The BMI and the serum albumin levels in the SCC patients were significantly lower compared with those in adenoCa patients. There were no differences in terms of surgical approach, outcome and postoperative complications. As regards pathological findings, 50% of the adenoCa group and 27.3% of the SCC group had mediastinal LNM. Abdominal LNM was more prevalent in the adenoCa group compared with the SCC group (100 vs. 54.6%, respectively; P=0.026); however, there were no significant differences in the recurrence pattern (local or distant) or in the overall survival between the two groups ( Fig. 1) .
A comparison between the groups with and without early recurrence is presented in Table III . The early recurrence group had a significantly longer operative time, and a greater prevalence of postoperative SSI and R1 resection compared with the non-early recurrence group. There was a significant difference in the overall survival between the two groups (Fig. 2) .
The results of survival analysis using the Kaplan-Meier method and log-rank test is shown in Table IV . The survival time of patients who underwent TAA (Fig. 3) , or had postoperative pneumonia (Fig. 4) , leakage (Fig. 5) , SSI (Fig. 6 ) and R1 (Fig. 7) , was significantly shorter compared with that of patients without these factors.
Discussion
The present study demonstrated that over one-third of patients with AEC (either SCC or adenoCa) had mediastinal LNM, and postoperative complications may be associated with poor prognosis. Conversely, differences in histological type and surgical approach did not appear to affect postoperative survival.
Previous studies reported that, in cases with adenoCa of the EGJ, Siewert type, histological type, tumor size and number of LNM were associated with prognosis (10) . In those studies, prognosis was found to be better in Siewert type I patients compared with type II or III patients (11) , and in patients with adenoCa compared with those with SCC (12) . In the present study, as over half of the cohort were SCC patients, it was observed that AEC corresponded to Siewert type I, with >30% of patients having mediastinal LNM. However, there was no difference between the SCC and adenoCa groups regarding the rate of mediastinal LNM or survival. In addition, 80% of patients who had R1 also experienced early recurrence. For these reasons, surgery for either SCC or adenoCa, without microscopic residual cancer (R0 resection), was crucial to the survival of AEC patients.
NAC or neoadjuvant chemoradiotherapy (NACRT) may achieve an increase in the R0 resection rate for AEC patients (13) . However, our data do not support the efficacy of NAC and adjuvant chemotherapy. As NAC was introduced to advances in the use of a thoraco-laparoscopic approach for esophageal cancer may result in the development of minimally invasive surgery with R0 resection, which may improve the prognosis of patients compared with a conventional approach (14) . Our data suggest an association between the development of postoperative complications and a poor prognosis. Table IV . Evaluation of variables associated with disease-specific survival using the Kaplan-Meier method with the log-rank test. Postoperative pneumonia after thoraco-abdominal esophagectomy has been reported to be associated with a poor prognosis (15, 16) . Markar et al reported an association between severe anastomotic leakage and a poor prognosis from 2,944 surgically treated esophageal cancer patients (17) . Although it was difficult to directly accept these data due to the high 90-day mortality rate (7.1%; 209/2,944), these postoperative complications may suppress the patient's immunological function (18) and result in early recurrence of cancer.
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The limitation of the present study is that it was retrospectively conducted with a small sample size. A multivariate analysis was performed using the Cox proportional hazards model, and found that pneumonia and R1 resection were negative predictive factors. However, due to small sample size, the hazard ratio and 95% confidence interval values were uncertain. In addition, the EGJ was difficult to define in some patients with advanced AEC, which made it more difficult to distinguish between Siewert types I and II. Further study is required to elucidate the risk of a poor prognosis for Siewert type I patients with AEC and to establish a treatment strategy.
The present study demonstrated the significance of R0 resection and prevention of postoperative complications for improving the prognosis of AEC patients. Further studies, such as prospective and multi-center investigations with large cohorts, are required to confirm short-and long-term outcomes, including the prognosis of AEC.
The present study was performed in accordance with the ethical standards laid down in the 1964 Declaration of Helsinki and its later amendments. Informed consent was obtained from all individual participants included in this study.
